c-src kinase inhibitor (Kissei Pharmaceutical)
90
Structured Review
Kissei Pharmaceutical
c-src kinase inhibitor
C Src Kinase Inhibitor, supplied by Kissei Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c-src+kinase+inhibitor/c+src+kinase+inhibitor/us12196758-408-26-30
Average 90 stars, based on 1 article reviews
C Src Kinase Inhibitor, supplied by Kissei Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c-src+kinase+inhibitor/c+src+kinase+inhibitor/us12196758-408-26-30
Average 90 stars, based on 1 article reviews
c-src kinase inhibitor - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Method for the diagnosis, prognosis and treatment of prostate cancer metastasis Article Snippet: In some aspects, the Src kinase inhibitor is selected from the group: AZD0530 (saracatinib), Bosulif (bosutinib), ENMD981693, KD0020, KX01, Sprycel (dasatinib), Yervoy (ipilimumab), AP23464, AP23485, AP23588, AZD0424, Article Title: Method for the diagnosis, prognosis and treatment of prostate cancer metastasis Article Snippet: In some aspects, the Src kinase inhibitor is selected from the group: AZD0530 (saracatinib), Bosulif (bosutinib), ENMD981693, KD020, KX01, Sprycel (dasatinib), Yervoy (ipilimumab), AP23464, AP23485, AP23588, AZD0424, Article Title: Method for the diagnosis, prognosis and treatment of lung cancer metastasis Article Snippet: In some aspects, the Src inhibitor is used to prevent or inhibit metastasis: In some aspects, the Src kinase inhibitor is selected from the group: AZD0530 (saracatinib), Bosulif (bosutinib), ENMD981693, KD020, KX01, Sprycel (dasatinib), Yervoy (ipilimumab), AP23464, AP23485, AP23588, AZD0424, Article Title: Method for the diagnosis, prognosis and treatment of prostate cancer metastasis Article Snippet: In some aspects, the Src kinase inhibitor is selected from the group: AZD0530 (saracatinib), Bosulif (bosutinib), ENMD981693, KD020, KX01, Sprycel (dasatinib), Yervoy (ipilimumab), AP23464, AP23485, AP23588, AZD0424, Article Title: Method for the prognosis and treatment of cancer metastasis Article Snippet: In some aspects, the Src kinase inhibitor is selected from the group: AZD0530 (saracatinib), Bosulif (bosutinib), ENMD981693, KDO20, KX01, Sprycel (dasatinib), Yervoy (ipilimumab), AP23464, AP23485, AP23588, AZD0424, Article Title: Method for the diagnosis, prognosis and treatment of prostate cancer metastasis Article Snippet: In some aspects, the Src kinase inhibitor is selected from the group: AZD0530 (saracatinib), Bosulif (bosutinib), ENMD981693, KD020, KX01, Sprycel (dasatinib), Yervoy (ipilimumab), AP23464, AP23485, AP23588, AZD0424, Article Title: Method for the prognosis and treatment of cancer metastasis Article Snippet: In some aspects, the Src kinase inhibitor is selected from the group: AZD0530 (saracatinib), Bosulif (bosutinib), ENMD981693, KD020, KX01 Sprycel (dasatinib), Yervoy (ipilimumab), AP23464, AP23485, AP23588, AZD0424, |